Dialysis modality and quality of life: more answers yet more questions.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39428172.
- Also identified by DOI 10.1016/j.kint.2024.08.028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Persons with end-stage kidney disease treated with dialysis experience distressing reductions in quality of life and increased mortality. Few large, randomized trials in nephrology have reported on health-related quality of life. Rose et al. report beneficial effects of high-volume hemodiafiltration versus high-flux hemodialysis on secondary end points of health-related quality of life in the CONVINCE trial (Comparison of High Dose Hemodiafiltration with High Flux Hemodialysis Trial). These results raise questions regarding hemodiafiltration as a potential modality to preserve health-related quality of life in end-stage kidney disease.
Medical subject headings
- Quality of Life
- Kidney Failure, Chronic
- Hemodiafiltration